Helus Pharma (Nasdaq: HELP, Cboe CA: HELP), a clinical-stage company developing treatments for depression and anxiety, has appointed Michael Halstead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE